Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2

doi:10.1001/jamaneurol.2021.3287

. 2021 Nov 1;78(11):1409-1411.

doi: 10.1001/jamaneurol.2021.3287.

Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2

Shirley Shapiro Ben David¹, Israel Potasman², Daniella Rahamim-Cohen¹

Affiliations

¹ Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.
² Internal Medicine and Infectious Diseases, Maccabi Healthcare Services, Haifa, Israel.

PMID: 34468703
PMCID: PMC8411356
DOI: 10.1001/jamaneurol.2021.3287

Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2

Shirley Shapiro Ben David et al. JAMA Neurol. 2021.

. 2021 Nov 1;78(11):1409-1411.

doi: 10.1001/jamaneurol.2021.3287.

Authors

Shirley Shapiro Ben David¹, Israel Potasman², Daniella Rahamim-Cohen¹

Affiliations

¹ Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.
² Internal Medicine and Infectious Diseases, Maccabi Healthcare Services, Haifa, Israel.

PMID: 34468703
PMCID: PMC8411356
DOI: 10.1001/jamaneurol.2021.3287

Abstract

This study establishes rates of Guillain-Barré syndrome relapse among Pfizer-BioNTech BNT162b2 vaccine receivers.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Cited by

Vaccine patterns among older adults with Guillain-Barré syndrome and matched comparators, 2006-2019.
Eiffert SR, Kinlaw AC, Sleath BL, Thorpe CT, Traub R, Raman SR, Stürmer T. Eiffert SR, et al. J Am Geriatr Soc. 2024 Oct;72(10):3055-3067. doi: 10.1111/jgs.19110. Epub 2024 Aug 1. J Am Geriatr Soc. 2024. PMID: 39090827
Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis.
Shabani M, Shobeiri P, Nouri S, Moradi Z, Amenu RA, Mehrabi Nejad MM, Rezaei N. Shabani M, et al. Eur J Med Res. 2024 Jan 17;29(1):55. doi: 10.1186/s40001-024-01639-4. Eur J Med Res. 2024. PMID: 38229141 Free PMC article. Review.
Vaccine patterns among patients diagnosed with Guillain-Barré Syndrome and matched counterparts in a Medicare supplemental population, 2000-2020.
Eiffert SR, Stürmer T, Thorpe CT, Traub R, Raman SR, Pate V, Kinlaw AC. Eiffert SR, et al. Vaccine. 2023 Sep 7;41(39):5763-5768. doi: 10.1016/j.vaccine.2023.08.014. Epub 2023 Aug 10. Vaccine. 2023. PMID: 37573203 Free PMC article.
Uptake of severe acute respiratory syndrome coronavirus 2 spike protein mediated by angiotensin converting enzyme 2 and ganglioside in human cerebrovascular cells.
McQuaid C, Solorzano A, Dickerson I, Deane R. McQuaid C, et al. Front Neurosci. 2023 Feb 16;17:1117845. doi: 10.3389/fnins.2023.1117845. eCollection 2023. Front Neurosci. 2023. PMID: 36875642 Free PMC article.
Guillain-Barre syndrome following COVID-19 vaccines: A review of literature.
Yu M, Nie S, Qiao Y, Ma Y. Yu M, et al. Front Immunol. 2023 Feb 15;14:1078197. doi: 10.3389/fimmu.2023.1078197. eCollection 2023. Front Immunol. 2023. PMID: 36875094 Free PMC article. Review.

See all "Cited by" articles

References

1. Israeli Ministry of Health . Coronavirus (COVID-19) vaccines. Accessed April 30, 2021. https://www.health.gov.il/UnitsOffice/HD/PH/epidemiology/td/docs/365_Cor....
1. Centers for Disease Control and Prevention. COVID-19 vaccines for people with underlying medical conditions. Accessed April 27, 2021. https://www.cdc.gov/coronavirus/2019-ancov/vaccines/recommendations/unde....
1. Vellozzi C, Iqbal S, Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis. 2014;58(8):1149-1155. doi:10.1093/cid/ciu005 - DOI - PubMed
1. Martín Arias LH, Sanz R, Sáinz M, Treceño C, Carvajal A. Guillain-Barré syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015;33(31):3773-3778. doi:10.1016/j.vaccine.2015.05.013 - DOI - PubMed
1. Lunn MP, Cornblath DR, Jacobs BC, et al. . COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations. Brain. 2021;144(2):357-360. doi:10.1093/brain/awaa444 - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- H1 Connect
Medical
- MedlinePlus Health Information

[1] Israeli Ministry of Health . Coronavirus (COVID-19) vaccines. Accessed April 30, 2021. https://www.health.gov.il/UnitsOffice/HD/PH/epidemiology/td/docs/365_Cor....

[2] Israeli Ministry of Health . Coronavirus (COVID-19) vaccines. Accessed April 30, 2021. https://www.health.gov.il/UnitsOffice/HD/PH/epidemiology/td/docs/365_Cor....

[3] Centers for Disease Control and Prevention. COVID-19 vaccines for people with underlying medical conditions. Accessed April 27, 2021. https://www.cdc.gov/coronavirus/2019-ancov/vaccines/recommendations/unde....

[4] Centers for Disease Control and Prevention. COVID-19 vaccines for people with underlying medical conditions. Accessed April 27, 2021. https://www.cdc.gov/coronavirus/2019-ancov/vaccines/recommendations/unde....

[5] Vellozzi C, Iqbal S, Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis. 2014;58(8):1149-1155. doi:10.1093/cid/ciu005 - DOI - PubMed

[6] Vellozzi C, Iqbal S, Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis. 2014;58(8):1149-1155. doi:10.1093/cid/ciu005 - DOI - PubMed

[7] Martín Arias LH, Sanz R, Sáinz M, Treceño C, Carvajal A. Guillain-Barré syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015;33(31):3773-3778. doi:10.1016/j.vaccine.2015.05.013 - DOI - PubMed

[8] Martín Arias LH, Sanz R, Sáinz M, Treceño C, Carvajal A. Guillain-Barré syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015;33(31):3773-3778. doi:10.1016/j.vaccine.2015.05.013 - DOI - PubMed

[9] Lunn MP, Cornblath DR, Jacobs BC, et al. . COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations. Brain. 2021;144(2):357-360. doi:10.1093/brain/awaa444 - DOI - PMC - PubMed

[10] Lunn MP, Cornblath DR, Jacobs BC, et al. . COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations. Brain. 2021;144(2):357-360. doi:10.1093/brain/awaa444 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2

Affiliations

Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical